Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Income towards Parent Company (2016 - 2025)

OptimizeRx's Income towards Parent Company history spans 16 years, with the latest figure at $779000.0 for Q3 2025.

  • For Q3 2025, Income towards Parent Company rose 108.54% year-over-year to $779000.0; the TTM value through Sep 2025 reached $4.8 million, up 115.2%, while the annual FY2024 figure was -$15.3 million, 12.82% up from the prior year.
  • Income towards Parent Company for Q3 2025 was $779000.0 at OptimizeRx, down from $1.5 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $4.7 million in Q4 2024 and bottomed at -$11.7 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$2.9 million (2023), against an average of -$2.7 million.
  • The largest annual shift saw Income towards Parent Company crashed 8790.01% in 2022 before it skyrocketed 140.19% in 2024.
  • A 5-year view of Income towards Parent Company shows it stood at $623462.0 in 2021, then crashed by 152.26% to -$325836.0 in 2022, then tumbled by 3502.9% to -$11.7 million in 2023, then surged by 140.19% to $4.7 million in 2024, then crashed by 83.49% to $779000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Income towards Parent Company are $779000.0 (Q3 2025), $1.5 million (Q2 2025), and -$2.2 million (Q1 2025).